GENEVA — Health authorities around the world are renewing warnings about hantavirus following a cluster of cases reported aboard a transatlantic cruise vessel in May 2026, prompting fresh scrutiny of an infectious disease that remains poorly understood by the general public even as it claims dozens of lives annually across multiple continents.
Hantavirus is a family of RNA viruses carried primarily by rodents, with different species of rodent serving as reservoir hosts in different geographic regions. Humans typically become infected not through direct bites but through contact with the urine, feces, or saliva of infected animals, or by inhaling airborne particles contaminated by rodent excretions — a route of transmission that makes enclosed or poorly ventilated environments particularly hazardous.
The disease manifests in two principal clinical syndromes. In the Americas, the predominant form is Hantavirus Pulmonary Syndrome, or HPS, which begins with fatigue, fever, and muscle aches before progressing rapidly to severe respiratory distress. Case fatality rates for HPS historically range from 30 to 40 percent, according to data compiled by the Pan-American Infectious Disease Surveillance Network. In Europe and Asia, the dominant syndrome is Hemorrhagic Fever with Renal Syndrome, or HFRS, which targets kidney function and carries a lower but still significant mortality rate of between one and 15 percent depending on the strain involved.
Dr. Mariana Velasquez, an infectious disease specialist at the Instituto de Salud Pública in Montevideo, said the recent cruise ship cluster has underscored how the virus can find pathways into environments that people consider low-risk. “People think of hantavirus as a disease you get hiking in a forest or cleaning out an old barn,” she said. “But any space where rodents have nested — a ship’s cargo hold, a storage room, an improperly sealed kitchen — can harbor infectious material for weeks after the rodents themselves have left.”
There is currently no approved antiviral treatment specifically targeting hantavirus, and no widely available vaccine for the strains most common outside of South Korea, which licensed a vaccine against the Seoul virus variant more than two decades ago. Management of severe cases relies on supportive care, including mechanical ventilation for HPS patients and dialysis for those with HFRS. Early recognition of symptoms and rapid transfer to intensive care facilities are considered the most critical determinants of patient survival.
Public health agencies emphasize that person-to-person transmission of most hantavirus strains is not a significant concern, with one notable exception: the Andes virus, found in parts of South America, has been documented in limited clusters of apparent human-to-human spread. That characteristic has made Andes virus a subject of particular scientific interest and concern.
Preventive measures focus on reducing rodent exposure. The World Health Organization recommends sealing gaps and cracks in buildings, storing food in rodent-proof containers, using gloves and respiratory protection when cleaning areas where rodents may have been present, and avoiding disturbing rodent burrows or nesting sites. Outdoor workers, campers, and those occupying seasonally closed cabins or rural structures face elevated risk.
Surveillance data suggest that hantavirus infections show seasonal patterns linked to fluctuations in rodent populations, which in turn respond to changes in food availability and climate conditions. Researchers at the Zoonotic Diseases Research Institute in Prague published findings last year indicating that milder winters across central Europe had contributed to higher rodent densities, correlating with an uptick in HFRS hospitalizations across five countries during the spring months of 2025. “We are watching climate-related shifts in the epidemiology of these infections,” said the study’s lead author, Dr. Tomas Hradecky. “What was once a disease of predictable seasonality is becoming harder to forecast.”
Global health authorities say the cruise ship incident, which led to the evacuation of at least three passengers with suspected hantavirus illness, is expected to prompt a review of biosecurity and pest-control protocols aboard commercial vessels. Investigations are ongoing, and definitive confirmation of cases awaits laboratory analysis. Officials have urged anyone who develops fever, muscle pain, or breathing difficulty after potential rodent exposure to seek medical attention promptly and to inform clinicians of that exposure history.
Looking further ahead, researchers say an effective broadly protective vaccine against multiple hantavirus strains remains a priority but a difficult one, given the genetic diversity across the virus family and the relatively limited commercial market compared with diseases affecting larger urban populations. Funding for hantavirus research has historically been modest in proportion to the disease’s impact, a disparity that advocacy groups have pressed global health funders to address. Several academic consortia are currently in early-stage development of mRNA-based vaccine candidates that they hope could eventually cover the most dangerous strains simultaneously, though clinical trials remain years away.